• 1. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 2. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 3. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 4. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 5. Excited state potential energy surfaces and their interactions in FeIVO active sites
  Shaun D. Wong,Edward I. Solomon Dalton Trans., 2014,43, 17567-17577

Comprehensive Overview of (3,5-dimethylphenyl)methanesulfonamide (CAS No. 919354-58-8)

(3,5-dimethylphenyl)methanesulfonamide (CAS No. 919354-58-8) is a specialized organic compound that has garnered significant attention in pharmaceutical and chemical research. This sulfonamide derivative is characterized by its unique molecular structure, featuring a methanesulfonamide group attached to a 3,5-dimethylphenyl ring. The compound's distinct properties make it a valuable intermediate in the synthesis of bioactive molecules, particularly in the development of novel therapeutic agents.

The growing interest in (3,5-dimethylphenyl)methanesulfonamide is driven by its potential applications in drug discovery and medicinal chemistry. Researchers are increasingly exploring its role as a building block for small-molecule inhibitors and enzyme modulators, which are critical in targeting diseases such as cancer, inflammation, and metabolic disorders. Its CAS No. 919354-58-8 serves as a unique identifier in chemical databases, ensuring accurate referencing in scientific literature and patents.

One of the key advantages of (3,5-dimethylphenyl)methanesulfonamide lies in its synthetic versatility. The compound can be further functionalized to introduce additional pharmacophoric groups, enhancing its binding affinity and selectivity. This adaptability aligns with current trends in precision medicine and structure-activity relationship (SAR) studies, where researchers aim to optimize drug candidates for specific biological targets.

In the context of green chemistry and sustainable synthesis, (3,5-dimethylphenyl)methanesulfonamide has also been evaluated for its compatibility with eco-friendly reaction conditions. Recent studies highlight its potential in catalytic transformations and solvent-free reactions, addressing the pharmaceutical industry's push toward reducing environmental impact. This aligns with broader societal concerns about sustainable drug development and carbon footprint reduction.

From a commercial perspective, the demand for (3,5-dimethylphenyl)methanesulfonamide is rising due to its inclusion in proprietary drug formulations and research pipelines. Suppliers and manufacturers often highlight its high purity (>98%) and consistent batch-to-batch reproducibility, which are critical for GMP-compliant production. The compound's CAS No. 919354-58-8 is frequently searched in procurement databases, reflecting its importance in the fine chemicals market.

Analytical characterization of (3,5-dimethylphenyl)methanesulfonamide typically involves advanced techniques such as NMR spectroscopy, HPLC-MS, and X-ray crystallography. These methods confirm its structural integrity and purity, which are essential for regulatory submissions and intellectual property protection. The compound's stability under various storage conditions (e.g., inert atmosphere, low humidity) further enhances its utility in long-term research projects.

Looking ahead, (3,5-dimethylphenyl)methanesulfonamide is poised to play a pivotal role in emerging areas like proteolysis-targeting chimeras (PROTACs) and covalent inhibitors. Its modular structure allows for integration into bifunctional molecules, a strategy gaining traction in targeted protein degradation therapies. This positions the compound at the forefront of next-generation drug discovery.

In summary, (3,5-dimethylphenyl)methanesulfonamide (CAS No. 919354-58-8) represents a versatile and scientifically significant chemical entity. Its applications span from traditional medicinal chemistry to cutting-edge therapeutic modalities, making it a subject of ongoing investigation and commercial interest. As research continues to uncover new possibilities, this compound is likely to remain a key player in the advancement of life sciences and pharmaceutical innovation.

• 4563-33-1(Phenylmethanesulfonamide)
• 64732-34-9((4-methylphenyl)methanesulfonamide)
• 112941-34-1((2-Methylphenyl)methanesulfonamide)
• 64732-38-3((4-Bromophenyl)methanesulfonamide)
• 64732-35-0((4-ethylphenyl)methanesulfonamide)
• 867262-52-0((2,6-dimethylphenyl)methanesulfonamide)
• 191868-54-9((4-cyanophenyl)methanesulfonamide)
• 919354-60-2((2,5-dimethylphenyl)methanesulfonamide)
• 110654-38-1((3-Methylphenyl)methanesulfonamide)
• 4403-84-3((4-aminophenyl)methanesulfonamide)